Medication options - Offering both oral and injectable formulations, as well as both semaglutide and tirzepatide, gives users some choice in how they approach treatment
Other GLP-1/GIP/GCG Triple Agonists in Development Besides retatrutide, several GLP-1/GIP/GCG triple agonists are in early-stage clinical trials (Table 3), though the WL efficacy associated with these medications remains unknown
Explore personalized health & wellness therapies Start Losing Weight in 3 Easy Steps Ready to take your first step
Common side effects The common side effects of semaglutide include the following: Constipation Diarrhea Headaches Hair loss Fatigue Fever Abdominal pain Confusion Belching Serious side effects The serious side effects of semaglutide are allergic reactions to the medication, inflammation of the pancreas, gallbladder problems, kidney diseases, diabetic retinopathy, and severe stomach issues
For weekly GLP-1 medications such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity), timing is less critical due to their extended half-lives and sustained therapeutic effects
doi: 10.1007/s10549-011-1585-0 54 ShadboorestanATarighiPKooshaMFaghihiHGhahremaniMHMontazeriH
